Replimune (REPL) Accounts Payables (2018 - 2026)

Replimune (REPL) reported Accounts Payables of $6.7 million for Q1 2026, down 46.47% on a YoY basis from $12.5 million in Q1 2025, and up 18.13% sequentially from $5.6 million in Q4 2025.

Replimune (REPL) Accounts Payables (2018 - 2026) Analysis & Trends

Replimune (REPL) has 9 years of Accounts Payables data on file, last reported at $6.7 million in Q1 2026.

  • For the quarter ending Q1 2026, Accounts Payables fell 46.47% year-over-year to $6.7 million; the trailing twelve-month figure through Mar 2026 stood at $6.7 million (down 46.47% YoY), and the FY2026 full-year result was $6.7 million, down 46.47% from the prior year.
  • Accounts Payables advanced to $6.7 million in Q1 2026, from $5.6 million in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $15.5 million in Q2 2025 to a low of $864000.0 in Q2 2024.
  • A 5-year average of $5.9 million and a median of $4.9 million in 2023 frame the typical range for Accounts Payables.
  • Across the five-year window, Accounts Payables tumbled 82.31% in 2024 and jumped 1692.01% in 2025, its largest moves.
  • Tracing REPL's Accounts Payables over 5 years: stood at $3.6 million in 2022, then increased by 6.99% to $3.9 million in 2023, then jumped by 84.17% to $7.2 million in 2024, then dropped by 21.44% to $5.6 million in 2025, then advanced by 18.13% to $6.7 million in 2026.
  • Business Quant data shows REPL's Accounts Payables at $6.7 million in Q1 2026, $5.6 million in Q4 2025, and $6.4 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 5.74 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 10.62 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 423.55 Mn
4 NuCana 279.75 Bn 279.75 Bn - 694,346.76
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 489.30 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 1.03 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.52 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 80.54 Mn
10 Replimune 970.73 Mn 970.73 Mn - 6.67 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 6.67 Mn
Dec 31, 2025 5.65 Mn
Sep 30, 2025 6.40 Mn
Jun 30, 2025 15.48 Mn
Mar 31, 2025 12.46 Mn
Dec 31, 2024 7.19 Mn
Sep 30, 2024 8.41 Mn
Jun 30, 2024 864,000.00
Mar 31, 2024 2.58 Mn
Dec 31, 2023 3.90 Mn
Sep 30, 2023 4.37 Mn
Jun 30, 2023 4.88 Mn
Mar 31, 2023 5.36 Mn
Dec 31, 2022 3.65 Mn
Sep 30, 2022 4.00 Mn
Jun 30, 2022 4.48 Mn
Mar 31, 2022 3.73 Mn
Dec 31, 2021 3.92 Mn
Sep 30, 2021 3.15 Mn
Jun 30, 2021 2.38 Mn